Using human embryos to test drugs will save animal lives
The Scottish scientist who created Dolly the sheep, the world’s first cloned mammal, Ian Wilmut, says that using embryonic stem cells to test drugs is more ethical and effective than using animals. The lives of thousands of animals could be saved, he said in Glasgow.
Dr Wilmut is doing research on amyotrophic lateral sclerosis (ALS), a disease which causes progressive paralysis. “Using animals to test drugs for ALS costs tens of thousands of pounds and the effects cannot be seen for a long time. If we develop a laboratory test, in a period of days you could test many more drugs for far less money and not use animals at all,” he said. He dismissed the notion of doing this research with adult stem cells which are unencumbered by ethical controversy. “So far, no scientist has been able to specifically turn any adult stem cell population into good populations of motor-neuron cells,” he observed.
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...